Format

Send to

Choose Destination
Biomed J. 2015 Mar-Apr;38(2):102-10. doi: 10.4103/2319-4170.148904.

APOBEC3B: pathological consequences of an innate immune DNA mutator.

Author information

1
Masonic Cancer Center; Institute for Molecular Virology; Center for Genome Engineering; Biochemistry, Molecular Biology and Biophysics Department, University of Minnesota, Minneapolis, MN, USA.

Abstract

Cancer is a disease that results from alterations in the cellular genome. Several recent studies have identified mutational signatures that implicate a variety of mutagenic processes in cancer, a major one of which is explained by the enzymatic activity of the DNA cytosine deaminase, APOBEC3B. As a deaminase, APOBEC3B converts cytosines to uracils in single-stranded DNA. Failure to properly repair these uracil lesions can result in a diverse array of mutations. For instance, DNA uracils can template the insertion of complementary adenines leading to C-to-T transition mutations. DNA uracils can also be converted into abasic sites that, depending upon the DNA polymerase recruited to bypass this lesion in the template strand, can lead to adenine insertion and C-to-T mutations as well as cytosine insertion and C-to-G transversion mutations. Finally, DNA uracils can also be converted into DNA breaks that may precipitate some types of larger chromosomal aberrations observed in cancer. These studies cumulatively demonstrate that APOBEC3B is a major source of genetic heterogeneity in several human cancers and, as such, this enzyme may prove to be a critical diagnostic and therapeutic target.

PMID:
25566802
DOI:
10.4103/2319-4170.148904
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Chang Gung Medical Hospital
Loading ...
Support Center